Lebenthal Global Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Lebenthal Global Advisors's BMY Position: Q4 2025 in Review
Lebenthal Global Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 13,888 shares — an estimated $626K sold.
Lebenthal Global Advisors first reported a position in BMY in Q4 2020 and held it in 17 quarters. The position peaked at $1.01M in Q2 2021. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Lebenthal Global Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Lebenthal Global Advisors sold 13,888 Bristol-Myers Squibb shares in Q4 2025, an estimated $626K.
- Lebenthal Global Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 17 quarters.
- Lebenthal Global Advisors's Bristol-Myers Squibb position peaked at $1.01M in Q2 2021.
- 2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Lebenthal Global Advisors's 13F filing for Q4 2025, filed 28 Jan 2026.